Cardiovascular effects of B-vitamins and/or N-3 fatty acids: The Su.Fol.Om3 trial

International Journal of Cardiology

Volumn 167, Issue 2, 2013, Pages 508-513

  Blacher, Jacques ^a,b   Czernichow, Sébastien ^e   Paillard, François ^c   Ducimetiere, Pierre ^d   Hercberg, Serge ^b   Galan, Pilar ^b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b UNIVERSITÉ PARIS 13   (France)

^c PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

^e LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

B vitamins; Coronary events; Omega 3 fatty acids; Revascularization; Secondary prevention

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CYANOCOBALAMIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOLIC ACID; INSULIN; OMEGA 3 FATTY ACID; PLACEBO; PYRIDOXINE; THIAZIDE DIURETIC AGENT;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HUMAN; INTENTION TO TREAT ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; VITAMIN BLOOD LEVEL;

AGED; CORONARY DISEASE; DOUBLE-BLIND METHOD; FATTY ACIDS, OMEGA-3; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; SECONDARY PREVENTION; TREATMENT OUTCOME; VITAMIN B COMPLEX;

EID: 84879086358     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.01.060     Document Type: Article

References (17)

1. P. Galan, S. Briancon, J. Blacher, S. Czernichow, and S. Hercberg The SU-FOL-OM3 study. A secondary prevention trial testing the impact of supplementation with folate and B-vitamins and/or Omega-3 PUFA on fatal and non fatal cardiovascular events, design, methods and participants characteristics Trials 9 2008 35
2. P. Saravanan, N.C. Davidson, E.B. Schmidt, and P.C. Calder Cardiovascular effects of marine omega-3 fatty acids Lancet 375 2010 540 550
3. P.C. Calder n-3 fatty acids and cardiovascular disease: evidence explained and mechanisms explored Clin Sci 107 2004 1 11
4. K.S. McCully Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis Am J Pathol 56 1969 111 128
5. P. Galan, E. Kesse-Guyot, and S. Czernichow Effects of B-vitamins and omega 3 fatty acids on cardiovascular diseases: a randomized placebo-controlled trial BMJ 341 2010 c6273
6. R. Clarke, J. Halsey, and S. Lewington B-Vitamin Treatment Trialists' Collaboration. Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals Arch Intern Med 170 2010 1622 1631
7. L. Venkitachalam, K.E. Kip, and F. Selzer Twenty-year evolution of percutaneous coronary intervention and its impact on clinical outcomes: a report from the National Heart, Lung, and Blood Institute-sponsored, multicenter 1985-1986 PTCA and 1997-2006 Dynamic Registries Circ Cardiovasc Interv 2 2009 6 13
8. S.D. Weiner, and L.E. Rabbani Secondary prevention strategies for coronary heart disease J Thromb Thrombolysis 29 2010 8 24
9. G. Schnyder, M. Roffi, and R. Pin Decreased rate of coronary restenosis after lowering of plasma homocysteine levels N Engl J Med 345 2001 1593 1600
10. GISSI Prevenzione investigators Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI Prevenzione trial Lancet 354 1999 447 455
11. D. Kromhout, E.J. Giltay, J.M. Geleijnse for the Alpha Omega Trial Group n-3 fatty acids and cardiovascular events after myocardial infarction N Engl J Med 363 2010 2015 2026
12. J.C. Tsai Induction of cyclin A gene expression by homocysteine in vascular smooth muscle cells J Clin Invest 97 1996 146 163
13. G. Ntaios, C. Savopoulos, D. Grekas, and A. Hatzitolios The controversial role of B-vitamins in cardiovascular risk: an update Arch Cardiovasc Dis 102 2009 847 854
14. H. Lange, H. De Suryapranata, and G. Luca Folate therapy and in-stent restenosis after coronary stenting N Engl J Med 350 2004 2673 2681
15. K.H. Bonaa, I. Njolstad, and P.M. Ueland Homocysteine lowering and cardiovascular events after acute myocardial infarction N Engl J Med 354 2006 1578 1588
16. K.H. Loland, O. Bleie, and A.J. Blix Effect of homocysteine-lowering B vitamin treatment on angiographic progression of coronary artery disease: a Western Norway B Vitamin Intervention Trial (WENBIT) substudy Am J Cardiol 105 2010 1577 1584
17. J. Loscalzo Homocysteine trials-clear outcomes for complex reasons N Engl J Med 354 2006 1629 1632